STOCK TITAN

Tilray to Webcast Annual Meeting of Stockholders on November 22, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Tilray invites stockholders to its Annual Meeting on November 22, 2021, at 11:00 a.m. EST, to be held virtually due to the ongoing COVID-19 pandemic. The record date for eligible stockholders was September 24, 2021. All shareholders are encouraged to vote and submit proxies if they have not done so. For those attending, a control number is required to join and participate in discussions and voting during the meeting. Tilray, operational in over 20 countries, is a leading cannabis and consumer goods company dedicated to enhancing the well-being of its consumers.

Positive
  • None.
Negative
  • None.

NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Tilray, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), invites all stockholders of record to attend the Annual Meeting of Stockholders (“Annual Meeting”) which will be held on November 22, 2021 at 11:00 a.m. EST. The record date for the Annual Meeting was September 24, 2021. In light of the ongoing public health crisis caused by the COVID-19 pandemic, the Annual Meeting will be held in a virtual format only, via live webcast over the internet.

It is important that all shares be represented and voted at the Annual Meeting. Whether or not stockholders plan to attend the Annual Meeting, the Company encourages them to submit their proxy as soon as possible if they have not already done so.

Stockholders who have their control number will be able to join, vote, and submit questions online during the Annual Meeting by visiting www.virtualshareholdermeeting.com/TLRY2021. Please log in 15 minutes prior to the start of the meeting.

For stockholders that come through their brokerage firm's website and do not have their control number, they can gain access to the meeting by logging into their brokerage firm's website 15 minutes prior to the meeting start, selecting the shareholder communications mailbox to link through to the meeting, and the control number will automatically populate.

About Tilray:
Tilray, Inc. (Nasdaq: TLRY; TSX: TLRY) is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people's lives for the better – one person at a time – by inspiring and empowering the worldwide community to live their very best life by providing them with products that meet the needs of their mind, body, and soul and invoke a sense of wellbeing. Tilray's mission is to be the trusted partner for its patients and consumers by providing them with a cultivated experience and health and wellbeing through high-quality, differentiated brands and innovative products. A pioneer in cannabis research, cultivation, and distribution, Tilray's unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and alcoholic beverages.
For more information about Tilray, visit www.Tilray.com

Forward-Looking Statements
Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, "forward-looking statements") under Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the "safe harbor" created by those sections and other applicable laws. Forward-looking statements can be identified by words such as "forecast," "future," "should," "could," "enable," "potential," "contemplate," "believe," "anticipate," "estimate," "plan," "expect," "intend," "may," "project," "will," "would" and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Many factors could cause actual results, performance or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with applicable securities regulatory authorities and available on SEDAR and EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities laws.

For further information:

Investors:
Raphael Gross, +1-203-682-8253, Raphael.Gross@icrinc.com

Media:
Berrin Noorata, news@tilray.com


FAQ

When is Tilray's Annual Meeting for stockholders?

Tilray's Annual Meeting is scheduled for November 22, 2021, at 11:00 a.m. EST.

How can I attend Tilray's Annual Meeting?

The Annual Meeting will be held virtually. Stockholders can join by visiting the designated webcast link.

What is the record date for Tilray's Annual Meeting?

The record date for Tilray's Annual Meeting was September 24, 2021.

What should stockholders do before the Annual Meeting?

Stockholders are urged to submit their proxy and ensure their shares are represented at the meeting.

What is Tilray's mission as a company?

Tilray's mission is to provide high-quality products that enhance the health and well-being of its consumers.

Tilray Brands, Inc.

NASDAQ:TLRY

TLRY Rankings

TLRY Latest News

TLRY Stock Data

1.22B
903.29M
0.67%
11.11%
13.08%
Drug Manufacturers - Specialty & Generic
Medicinal Chemicals & Botanical Products
Link
United States of America
NEW YORK